Search

Your search keyword '"Zhai, Tian-Tian"' showing total 26 results
Start Over Author "Zhai, Tian-Tian"
26 results on '"Zhai, Tian-Tian"'

8. CT‐based deep multi‐label learning prediction model for outcome in patients with oropharyngeal squamous cell carcinoma

Author

Ma, Baoqiang, primary, Guo, Jiapan, additional, Zhai, Tian‐Tian, additional, van der Schaaf, Arjen, additional, Steenbakkers, Roel J. H. M., additional, van Dijk, Lisanne V., additional, Both, Stefan, additional, Langendijk, Johannes A., additional, Zhang, Weichuan, additional, Qiu, Bingjiang, additional, van Ooijen, Peter M. A., additional, and Sijtsema, Nanna M., additional

Published
2023
Full Text
View/download PDF

14. More Accurate Definition of Clinical Target Volume Based on the Measurement of Microscopic Extensions of the Primary Tumor Toward the Uterus Body in International Federation of Gynecology and Obstetrics Ib-IIa Squamous Cell Carcinoma of the Cervix

Author

Xie, Wen-Jia, Wu, Xiao, Xue, Ren-Liang, Lin, Xiang-Ying, Kidd, Elizabeth A., Yan, Shu-Mei, Zhang, Yao-Hong, Zhai, Tian-Tian, Lu, Jia-Yang, Wu, Li-Li, Zhang, Hao, Huang, Hai-Hua, Chen, Zhi-Jian, Li, De-Rui, and Xie, Liang-Xi

Published
2015
Full Text
View/download PDF

16. Comparison of survival, acute toxicities, and dose–volume parameters between intensity‐modulated radiotherapy with or without internal target volume delineation method and three‐dimensional conformal radiotherapy in cervical cancer patients: A retrospective and propensity score‐matched analysis

Author

Liang, Yu‐Qin, primary, Feng, Sen‐Quan, additional, Xie, Wen‐Jia, additional, Jiang, Qiong‐Zhi, additional, Yang, Yan‐Fen, additional, Luo, Ren, additional, Kidd, Elizabeth A., additional, Zhai, Tian‐Tian, additional, and Xie, Liang‐Xi, additional

Published
2021
Full Text
View/download PDF

19. Pre-treatment radiomic features predict individual lymph node failure for head and neck cancer patients

Author

Zhai, Tian-Tian, primary, Langendijk, Johannes A., additional, van Dijk, Lisanne V., additional, van der Schaaf, Arjen, additional, Sommers, Linda, additional, Vemer-van den Hoek, Johanna G.M., additional, Bijl, Henk P., additional, Halmos, Gyorgy B., additional, Witjes, Max J.H., additional, Oosting, Sjoukje F., additional, Noordzij, Walter, additional, Sijtsema, Nanna M., additional, and Steenbakkers, Roel J.H.M., additional

Published
2020
Full Text
View/download PDF

20. Comparison of survival, acute toxicities, and dose–volume parameters between intensity‐modulated radiotherapy with or without internal target volume delineation method and three‐dimensional conformal radiotherapy in cervical cancer patients: A retrospective and propensity score‐matched analysis

Author

Liang, Yu‐Qin, Feng, Sen‐Quan, Xie, Wen‐Jia, Jiang, Qiong‐Zhi, Yang, Yan‐Fen, Luo, Ren, Kidd, Elizabeth A., Zhai, Tian‐Tian, and Xie, Liang‐Xi

Subjects
INTENSITY modulated radiotherapy, CERVICAL cancer, PROGRESSION-free survival, CANCER patients, CANCER radiotherapy
Abstract

Background: To evaluate whether the use of the internal target volume (ITV) delineation method improves the performance of intensity‐modulated radiotherapy (IMRT) and three‐dimensional conformal radiotherapy (3DCRT) in terms of survival, acute toxicities, and dose–volume parameters. Methods: A total number of 477 cervical cancer patients who received concurrent chemoradiotherapy (CCRT) from January 2012 to December 2016 were retrospectively analyzed. They were divided into four groups: the non‐ITV (N‐ITV) + IMRT, ITV + IMRT, N‐ITV + 3DCRT, and ITV + 3DCRT groups, with 76, 41, 327, and 33 patients, respectively. Survival analysis was performed with the Kaplan–Meier and the log‐rank tests, and acute toxicity analysis was performed with the chi‐squared test and the binary logistic regression test. Using the propensity score matching (PSM) method, 92 patients were matched among the four groups, and their dose–volume parameters were assessed with the Kruskal–Wallis method. Results: The median follow‐up time was 49 months (1–119) for overall survival (OS). The 5‐year OS rate was 66.4%. The ITV delineation method was an independent prognostic factor for OS (HR [95% CI]: 0.52 [0.27, 0.98], p = 0.044) and progression‐free survival (PFS) (HR [95% CI]: 0.59 [0.36, 0.99], p = 0.045). The ITV + IMRT group had the lowest incidence rate (22%) and the N‐ITV + IMRT group had the highest incidence rate of grade ≥3 hematological toxicity (HT) (46.1%) among the four groups. The pelvic bone marrow relative V10, V20, and V30 in the N‐ITV + IMRT group was higher than those in the ITV + IMRT and N‐ITV + 3DCRT groups (p < 0.05). Conclusions: The use of ITV for IMRT treatment planning was associated with improved overall survival and progression‐free survival, with lower HT rate. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results